SDIC
NBIX icon

South Dakota Investment Council’s Neurocrine Biosciences NBIX Stock Holding History

South Dakota Investment Council’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,247
Closed -$304K – 632
2022
Q1 		$304K Sell
3,247
-16,853
-84% -$1.43M 0.01% 537
2021
Q4 		$1.71M Hold
20,100
– – 0.03% 387
2021
Q3 		$1.93M Buy
+20,100
New +$1.9M 0.03% 350

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

South Dakota Investment Council's NBIX Position: Q2 2022 in Review

South Dakota Investment Council sold out of Neurocrine Biosciences (NBIX) in Q2 2022, closing a stake of 3,247 shares — an estimated $304K sold.

South Dakota Investment Council first reported a position in NBIX in Q3 2021 and held it in 3 quarters. The position peaked at $1.93M in Q3 2021. 438 funds tracked by Wall St. Rank hold NBIX as of Q2 2022.

  • South Dakota Investment Council reported no remaining Neurocrine Biosciences position as of Q2 2022 after selling out during the quarter.
  • South Dakota Investment Council sold 3,247 Neurocrine Biosciences shares in Q2 2022, an estimated $304K.
  • South Dakota Investment Council first reported a position in Neurocrine Biosciences in Q3 2021 and held it in 3 quarters.
  • South Dakota Investment Council's Neurocrine Biosciences position peaked at $1.93M in Q3 2021.
  • 438 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2022.

Based on South Dakota Investment Council's 13F filing for Q2 2022, filed 11 Aug 2022.